XML 77 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The following table presents certain financial data for the Company’s reportable segment (in thousands):
December 31,
20242023
Clinical trial expenses $15,892 $7,066 
Employee related research and development expenses8,560 7,306 
Chemistry, manufacturing and controls expenses4,260 7,623 
Other research and development expenses5,971 5,553 
Contract and grant reimbursements(1,027)(3,800)
Employee related general and administrative expenses3,682 3,437 
Professional fees and other general and administrative expenses 7,648 8,455 
Other segment items 6,912 (445)
Segment net loss$51,898 $35,195 
Total segment assets$28,178 $27,146